查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
癌症活检市场（产品：平台和仪器、套件和试剂以及服务；类型：组织活检、液体活检和其他）- 2023-2031年全球行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1301441

癌症活检市场（产品：平台和仪器、套件和试剂以及服务；类型：组织活检、液体活检和其他）- 2023-2031年全球行业分析、规模、份额、增长、趋势和预测

Cancer Biopsy Market (Product: Platforms & Instruments, Kits & Reagents, and Services; Type: Tissue Biopsies, Liquid Biopsies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

癌症活检市场 - 报告的范围

TMR关于全球癌症活检市场的报告研究了过去以及当前的增长趋势和机会，以获得对2023年至2031年预测期间市场指标的宝贵见解。报告提供了2017-2031年期间全球癌症活检市场的收入，考虑到2023年为基准年，2031年为预测年。报告还提供了2023年至2031年全球癌症活检市场的复合年增长率（CAGR %）。

该报告是在广泛的研究后编写的。一级研究涉及大部分的研究工作，其中分析师与关键意见领袖、行业领袖和意见制造者进行了访谈。二级研究包括参考主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解癌症活检市场。

该报告深入研究了癌症活检的竞争格局。在全球癌症活检市场运作的主要参与者已被确定，其中每一个都在各种属性方面进行了分析。公司概况、财务状况、近期发展和SWOT是本报告对全球癌症活检市场参与者的属性描述。

目录

第一章：前言

  • 市场定义和范围
  • 市场细分
  • 主要研究目标
  • 研究重点

第二章：假设和研究方法

第三章：执行摘要：全球市场

第四章：市场概述

  • 简介
    • 细分市场的定义
  • 概述
  • 市场动态
    • 驱动力
    • 限制因素
    • 机会
  • 2017-2031年全球市场分析和预测
    • 市场收入预测

第五章：关键洞察力

  • 癌症患病率和发病率：按地区划分
  • 技术进步
  • COVID-19大流行对行业的影响（价值链和短期/中期/长期影响）。
  • 各地区/全球的报销情况
  • 价值链分析

第六章：全球市场分析与预测：按产品分类

  • 介绍和定义
  • 主要发现/发展
  • 市场价值预测：按产品分类，2017-2031年
    • 平台和仪器
    • 套件和试剂
    • 服务
  • 市场吸引力分析：按产品分类

第七章 ：全球市场分析和预测：按类型

  • 介绍和定义
  • 主要研究结果/发展
  • 市场价值预测：按类型，2017-2031年
    • 组织活检
      • 针刺活检
      • 手术活检
    • 液体活检
    • 其他类型
  • 市场吸引力分析：按类型

第八章：全球市场分析与预测：按应用分类

  • 介绍和定义
  • 主要研究结果/发展
  • 市场价值预测：按应用分类，2017-2031年
    • 乳腺癌
    • 结直肠癌
    • 宫颈癌
    • 肺癌
    • 前列腺癌
    • 皮肤癌
    • 血癌
    • 肾癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他
  • 市场吸引力分析：按应用分类

第九章：全球市场分析与预测：按地区划分

  • 主要发现
  • 市场价值预测：按地区划分，2017-2031年
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第十章：北美市场分析与预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品分类，2017-2031年
    • 平台和仪器
    • 套件和试剂
    • 服务
  • 市场价值预测：按类型划分，2017-2031年
    • 组织活检
      • 针刺活检
      • 手术活检
    • 液体活检
    • 其他类型
  • 市场价值预测：按应用分类，2017-2031年
    • 乳腺癌
    • 结直肠癌
    • 宫颈癌
    • 肺癌
    • 前列腺癌
    • 皮肤癌
    • 血癌
    • 肾癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市场价值预测：按国家划分，2017-2031年
    • 美国
    • 加拿大
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按应用分类
    • 按国家分类

第11章 ：欧洲市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品，2017-2031年
    • 平台和仪器
    • 套件和试剂
    • 服务
  • 市场价值预测：按类型划分，2017-2031年
    • 组织活检
      • 针刺活检
      • 手术活检
    • 液体活检
    • 其他类型
  • 市场价值预测：按应用分类，2017-2031年
    • 乳腺癌
    • 结直肠癌
    • 宫颈癌
    • 肺癌
    • 前列腺癌
    • 皮肤癌
    • 血癌
    • 肾癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市场价值预测：按国家/次区域，2017-2031年
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按应用分类
    • 按国家/次区域分类

第十二章 ：亚太地区市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品，2017-2031年
    • 仪器
    • 试剂盒和试剂
    • 服务
  • 市场价值预测：按类型划分，2017-2031年
    • 组织活检
      • 针刺活检
      • 手术活检
    • 液体活检
    • 其他类型
  • 市场价值预测：按应用分类，2017-2031年
    • 乳腺癌
    • 结直肠癌
    • 宫颈癌
    • 肺癌
    • 前列腺癌
    • 皮肤癌
    • 血癌
    • 肾癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市场价值预测：按国家/次区域划分，2017-2031年
    • 中国
    • 日本
    • 印度
    • 澳大利亚和新西兰
    • 亚太其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按应用分类
    • 按国家/次区域分类

第13章 ：拉美市场分析与预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品，2017-2031年
    • 平台&平台&仪器
    • 套件和试剂
    • 服务
  • 市场价值预测：按类型，2017-2031年
    • 组织活检
      • 针刺活检
      • 手术活检
    • 液体活检
    • 其他类型
  • 市场价值预测：按应用分类，2017-2031年
    • 乳腺癌
    • 结直肠癌
    • 宫颈癌
    • 肺癌
    • 前列腺癌
    • 皮肤癌
    • 血癌
    • 肾癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市场价值预测：按国家/次区域，2017-2031年
    • 巴西
    • 墨西哥
    • 拉美其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按应用分类
    • 按国家/次区域分类

第十四章：中东和非洲市场分析和预测

  • 介紹
    • 主要发现
  • 市场价值预测：按产品，2017-2031年
    • 平台和仪器
    • 套件和试剂
    • 服务
  • 市场价值预测：按类型划分，2017-2031年
    • 组织活检
      • 针刺活检
      • 手术活检
    • 液体活检
    • 其他类型
  • 市场价值预测：按应用分类，2017-2031年
    • 乳腺癌
    • 结直肠癌
    • 宫颈癌
    • 肺癌
    • 前列腺癌
    • 皮肤癌
    • 血癌
    • 肾癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市场价值预测：按国家/次区域划分，2017-2031年
    • 海湾合作委员会国家
    • 南非
    • 中东和非洲其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按应用分类
    • 按国家/次区域分类

第十五章 ：竞争格局

  • 市场参与者 - 竞争矩阵（按公司层级和规模）。
  • 市场份额分析：按公司划分，2022年
  • 公司简介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies, Inc.
    • Illumina, Inc.
    • Siemens Healthineers
    • GE Healthcare
    • Bio-Rad Laboratories, Inc.
    • Olympus Corporation
    • QIAGEN
Product Code: TMRGL85628

Cancer Biopsy Market - Scope of Report

TMR's report on the global Cancer Biopsy Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Cancer Biopsy Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Cancer Biopsy Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Cancer Biopsy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Cancer Biopsy.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Cancer Biopsy. These serve as valuable tools for existing market players as well as for entities interested in participating in the Cancer Biopsy.

The report delves into the competitive landscape of the Cancer Biopsy. Key players operating in the global Cancer Biopsy Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Cancer Biopsy Market profiled in this report.

Key Questions Answered in Global Cancer Biopsy Market Report:

  • What is the sales/revenue generated by Cancer Biopsy across all regions during the forecast period?
  • What are the opportunities in the Cancer Biopsy?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cancer Biopsy Market - Research Objectives and Research Approach

The comprehensive report on the global Cancer Biopsy Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Cancer Biopsy Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the Cancer Biopsy.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Biopsy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cancer Biopsy Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Cancer Prevalence & Incidence, by Region
  • 5.2. Technological Advancements
  • 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
  • 5.4. Reimbursement Scenario by Region/Globally
  • 5.5. Value Chain Analysis

6. Global Cancer Biopsy Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Platforms & Instruments
    • 6.3.2. Kits & Reagents
    • 6.3.3. Services
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Cancer Biopsy Market Analysis and Forecast, by Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Type, 2017-2031
    • 7.3.1. Tissue Biopsies
      • 7.3.1.1. Needle Biopsies
      • 7.3.1.2. Surgical Biopsies
    • 7.3.2. Liquid Biopsies
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Type

8. Global Cancer Biopsy Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Breast Cancer
    • 8.3.2. Colorectal Cancer
    • 8.3.3. Cervical Cancer
    • 8.3.4. Lung Cancer
    • 8.3.5. Prostate Cancer
    • 8.3.6. Skin Cancer
    • 8.3.7. Blood Cancer
    • 8.3.8. Kidney Cancer
    • 8.3.9. Liver Cancer
    • 8.3.10. Pancreatic Cancer
    • 8.3.11. Ovarian Cancer
    • 8.3.12. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Cancer Biopsy Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Cancer Biopsy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Platforms & Instruments
    • 10.2.2. Kits & Reagents
    • 10.2.3. Services
  • 10.3. Market Value Forecast, by Type, 2017-2031
    • 10.3.1. Tissue Biopsies
      • 10.3.1.1. Needle Biopsies
      • 10.3.1.2. Surgical Biopsies
    • 10.3.2. Liquid Biopsies
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Application, 2017-2031
    • 10.4.1. Breast Cancer
    • 10.4.2. Colorectal Cancer
    • 10.4.3. Cervical Cancer
    • 10.4.4. Lung Cancer
    • 10.4.5. Prostate Cancer
    • 10.4.6. Skin Cancer
    • 10.4.7. Blood Cancer
    • 10.4.8. Kidney Cancer
    • 10.4.9. Liver Cancer
    • 10.4.10. Pancreatic Cancer
    • 10.4.11. Ovarian Cancer
    • 10.4.12. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Type
    • 10.6.3. By Application
    • 10.6.4. By Country

11. Europe Cancer Biopsy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Platforms & Instruments
    • 11.2.2. Kits & Reagents
    • 11.2.3. Services
  • 11.3. Market Value Forecast, by Type, 2017-2031
    • 11.3.1. Tissue Biopsies
      • 11.3.1.1. Needle Biopsies
      • 11.3.1.2. Surgical Biopsies
    • 11.3.2. Liquid Biopsies
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Breast Cancer
    • 11.4.2. Colorectal Cancer
    • 11.4.3. Cervical Cancer
    • 11.4.4. Lung Cancer
    • 11.4.5. Prostate Cancer
    • 11.4.6. Skin Cancer
    • 11.4.7. Blood Cancer
    • 11.4.8. Kidney Cancer
    • 11.4.9. Liver Cancer
    • 11.4.10. Pancreatic Cancer
    • 11.4.11. Ovarian Cancer
    • 11.4.12. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Type
    • 11.6.3. By Application
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Cancer Biopsy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Instruments
    • 12.2.2. Kits & Reagents
    • 12.2.3. Services
  • 12.3. Market Value Forecast, by Type, 2017-2031
    • 12.3.1. Tissue Biopsies
      • 12.3.1.1. Needle Biopsies
      • 12.3.1.2. Surgical Biopsies
    • 12.3.2. Liquid Biopsies
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Breast Cancer
    • 12.4.2. Colorectal Cancer
    • 12.4.3. Cervical Cancer
    • 12.4.4. Lung Cancer
    • 12.4.5. Prostate Cancer
    • 12.4.6. Skin Cancer
    • 12.4.7. Blood Cancer
    • 12.4.8. Kidney Cancer
    • 12.4.9. Liver Cancer
    • 12.4.10. Pancreatic Cancer
    • 12.4.11. Ovarian Cancer
    • 12.4.12. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Type
    • 12.6.3. By Application
    • 12.6.4. By Country/Sub-region

13. Latin America Cancer Biopsy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Platforms & Platforms & Instruments
    • 13.2.2. Kits & Reagents
    • 13.2.3. Services
  • 13.3. Market Value Forecast, by Type, 2017-2031
    • 13.3.1. Tissue Biopsies
      • 13.3.1.1. Needle Biopsies
      • 13.3.1.2. Surgical Biopsies
    • 13.3.2. Liquid Biopsies
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Breast Cancer
    • 13.4.2. Colorectal Cancer
    • 13.4.3. Cervical Cancer
    • 13.4.4. Lung Cancer
    • 13.4.5. Prostate Cancer
    • 13.4.6. Skin Cancer
    • 13.4.7. Blood Cancer
    • 13.4.8. Kidney Cancer
    • 13.4.9. Liver Cancer
    • 13.4.10. Pancreatic Cancer
    • 13.4.11. Ovarian Cancer
    • 13.4.12. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Type
    • 13.6.3. By Application
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Cancer Biopsy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Platforms & Instruments
    • 14.2.2. Kits & Reagents
    • 14.2.3. Services
  • 14.3. Market Value Forecast, by Type, 2017-2031
    • 14.3.1. Tissue Biopsies
      • 14.3.1.1. Needle Biopsies
      • 14.3.1.2. Surgical Biopsies
    • 14.3.2. Liquid Biopsies
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Breast Cancer
    • 14.4.2. Colorectal Cancer
    • 14.4.3. Cervical Cancer
    • 14.4.4. Lung Cancer
    • 14.4.5. Prostate Cancer
    • 14.4.6. Skin Cancer
    • 14.4.7. Blood Cancer
    • 14.4.8. Kidney Cancer
    • 14.4.9. Liver Cancer
    • 14.4.10. Pancreatic Cancer
    • 14.4.11. Ovarian Cancer
    • 14.4.12. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Type
    • 14.6.3. By Application
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Becton, Dickinson and Company
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. F. Hoffmann-La Roche Ltd.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Hologic, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Danaher Corporation
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Thermo Fisher Scientific, Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Agilent Technologies, Inc.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Illumina, Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Siemens Healthineers
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. GE Healthcare
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Bio-Rad Laboratories, Inc.
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Olympus Corporation
      • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. SWOT Analysis
      • 15.3.12.5. Strategic Overview
    • 15.3.13. QIAGEN
      • 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. SWOT Analysis
      • 15.3.13.5. Strategic Overview

List of Tables

  • Table 01: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 03: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 05: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 06: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 09: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 10: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 12: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 13: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 15: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 16: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 17: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 18: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 19: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 21: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 22: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 24: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 25: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 27: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 28: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 30: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 31: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 33: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 34: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 35: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 36: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

List of Figures

  • Figure 01: Global Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 02: Global Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 03: Global Cancer Biopsy Market Revenue (US$ Mn), by Platforms & Instruments, 2017-2031
  • Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Kits & Reagents, 2017-2031
  • Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Services, 2017-2031
  • Figure 05: Global Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 06: Global Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 07: Global Cancer Biopsy Market Revenue (US$ Mn), by Tissue Biopsies, 2017-2031
  • Figure 08: Global Cancer Biopsy Market Revenue (US$ Mn), by Liquid Biopsies, 2017-2031
  • Figure 09: Global Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 10: Global Cancer Biopsy Market Attractiveness Analysis, Application, 2023-2031
  • Figure 11: Global Cancer Biopsy Market Revenue (US$ Mn), by Breast Cancer, 2017-2031
  • Figure 12: Global Cancer Biopsy Market Revenue (US$ Mn), by Colorectal Cancer, 2017-2031
  • Figure 13: Global Cancer Biopsy Market Revenue (US$ Mn), by Cervical Cancer 2022 and 2031
  • Figure 14: Global Cancer Biopsy Market Revenue (US$ Mn), Lung Cancer, 2023-2031
  • Figure 15: Global Cancer Biopsy Market Revenue (US$ Mn), by Prostate Cancer, 2017-2031
  • Figure 16: Global Cancer Biopsy Market Revenue (US$ Mn), by Skin Cancer, 2017-2031
  • Figure 17: Global Cancer Biopsy Market Revenue (US$ Mn), by Blood Cancer, 2017-2031
  • Figure 18: Global Cancer Biopsy Market Revenue (US$ Mn), Kidney Cancer, 2023-2031
  • Figure 19: Global Cancer Biopsy Market Revenue (US$ Mn), by Liver Cancer, 2017-2031
  • Figure 20: Global Cancer Biopsy Market Revenue (US$ Mn), by Pancreatic Cancer, 2017-2031
  • Figure 21: Global Cancer Biopsy Market Revenue (US$ Mn), by Ovarian Cancer, 2017-2031
  • Figure 22: Global Cancer Biopsy Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 23: Global Cancer Biopsy Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 24: Global Cancer Biopsy Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 25: North America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 26: North America Cancer Biopsy Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 27: North America Cancer Biopsy Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 29: North America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 30: North America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 31: North America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
  • Figure 32: North America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 33: North America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 34: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 35: Europe Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Europe Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Europe Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 38: Europe Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 39: Europe Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 40: Europe Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 41: Europe Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 42: Europe Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 43: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 44: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 45: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 47: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 48: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 49: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 50: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 51: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 52: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 53: Latin America Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 54: Latin America Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Latin America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 56: Latin America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 57: Latin America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 58: Latin America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
  • Figure 59: Latin America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 60: Latin America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 61: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 62: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 63: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 64: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 65: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 66: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 67: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
  • Figure 68: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 69: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 70: Global Cancer Biopsy Market Share Analysis, by Company 2022